Department of General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, China.
J Gastrointest Surg. 2011 Aug;15(8):1417-25. doi: 10.1007/s11605-011-1561-3. Epub 2011 May 17.
Hemorrhage from pseudoaneurysms after pancreatic surgery is a rare but life-threatening and complicated complication. The study presents our experience to provide therapeutic management for this rare condition.
Between February 1994 and January 2011, 35 patients experienced hemorrhage from pseudoaneurysms in our hospital. Medical data of this rare complication were analyzed retrospectively.
The prevalence of hemorrhage from pseudoaneurysms was 3.2% (35/1,102). Sixteen patients (45.7%) experienced sentinel bleeding. Pancreatic fistula (74.3%) and intra-abdominal abscess (57.1%) were two common complications prior to hemorrhage. Of 35 patients, 20 underwent endovascular intervention, 14 received surgical re-laparotomy, and bleeding stopped spontaneously in one. The overall mortality rate was 22.9%. Technical success rate of endovascular treatment was 87%. There were significant differences in the mortality rate (10.0% vs 42.9%), operation time (72.8 vs 123.9 min), estimated blood loss (1,835 vs 3,000 ml), and intensive care unit stay (3.6 vs 8.6 days) between endovascular and surgical treatment. Mean follow-up was 19.2 ± 17.0 (range, 5-63 months).
Endovascular intervention represents the first-line treatment for hemorrhage from pseudoaneurysms after pancreatic surgery. Endovascular embolization or stent-graft placement should be selected individually depending on the involved artery and its vascular anatomy.
胰腺手术后假性动脉瘤出血是一种罕见但危及生命且复杂的并发症。本研究介绍了我们的经验,为这种罕见情况提供治疗管理。
1994 年 2 月至 2011 年 1 月期间,我院有 35 例患者发生假性动脉瘤出血。回顾性分析该罕见并发症的医疗数据。
假性动脉瘤出血的患病率为 3.2%(35/1102)。16 例患者(45.7%)出现哨兵性出血。出血前常见的并发症为胰瘘(74.3%)和腹腔脓肿(57.1%)。35 例患者中,20 例行血管内介入治疗,14 例行再次剖腹手术,1 例自发性止血。总死亡率为 22.9%。血管内治疗的技术成功率为 87%。血管内治疗和手术治疗在死亡率(10.0%比 42.9%)、手术时间(72.8 比 123.9 分钟)、估计出血量(1835 比 3000 毫升)和重症监护病房停留时间(3.6 比 8.6 天)方面存在显著差异。平均随访 19.2±17.0 个月(范围 5-63 个月)。
血管内介入治疗是胰腺手术后假性动脉瘤出血的一线治疗方法。根据受累动脉及其血管解剖结构,应单独选择血管内栓塞或支架置入。